Advertisement
Screener

PFIZER INC (PFE) Other Comprehensive Income (Loss), Net of Tax

PFIZER INC Other Comprehensive Income (Loss), Net of Tax

PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Net of Tax of -$26.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04

  • PFIZER INC other comprehensive income (loss), net of tax for the quarter ending 2026-06-28 was -$26.00M, a 118.18% decline year-over-year.
  • PFIZER INC other comprehensive income (loss), net of tax for the quarter ending 2026-03-29 was $863.00M.
  • PFIZER INC other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was -$8.00M, a 105.30% decline year-over-year.
  • PFIZER INC other comprehensive income (loss), net of tax for the quarter ending 2025-09-28 was $367.00M.
  • PFIZER INC other comprehensive income (loss), net of tax for fiscal 2025 was -$239.00M, a 306.03% decline from fiscal 2024.
  • PFIZER INC other comprehensive income (loss), net of tax for fiscal 2024 was $116.00M, a 64.95% decline from fiscal 2023.
  • PFIZER INC other comprehensive income (loss), net of tax for fiscal 2023 was $331.00M.
  • PFIZER INC other comprehensive income (loss), net of tax for fiscal 2022 was -$2.42B.
Period endOther Comprehensive Income (Loss), Net of Tax 3 monthOther Comprehensive Income (Loss), Net of Tax 3 month as first filedOther Comprehensive Income (Loss), Net of Tax 6 monthOther Comprehensive Income (Loss), Net of Tax 6 month as first filedOther Comprehensive Income (Loss), Net of Tax 9 monthOther Comprehensive Income (Loss), Net of Tax 9 month as first filedOther Comprehensive Income (Loss), Net of Tax 12 monthOther Comprehensive Income (Loss), Net of Tax 12 month as first filed
2026-06-28-$26.00M
10-Q · filed 2026-08-04
$837.00M
10-Q · filed 2026-08-04
$829.00M
derived: sum of 3 quarters · filed 2026-08-04
$1.20B
derived: sum of 4 quarters · filed 2026-08-04
2026-03-29$863.00M
10-Q · filed 2026-05-05
$855.00M
derived: sum of 2 quarters · filed 2026-05-05
$1.22B
derived: sum of 3 quarters · filed 2026-05-05
$1.36B
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$359.00M
derived: sum of 2 quarters · filed 2026-02-26
$502.00M
derived: sum of 3 quarters · filed 2026-08-04
-$239.00M
10-K · filed 2026-02-26
2025-09-28$367.00M
10-Q · filed 2025-11-04
$510.00M
derived: sum of 2 quarters · filed 2026-08-04
-$231.00M
10-Q · filed 2025-11-04
-$80.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-29$143.00M
10-Q · filed 2026-08-04
-$598.00M
10-Q · filed 2026-08-04
-$447.00M
derived: sum of 3 quarters · filed 2026-08-04
-$613.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-30-$741.00M
10-Q · filed 2026-05-05
-$590.00M
derived: sum of 2 quarters · filed 2026-05-05
-$756.00M
derived: sum of 3 quarters · filed 2026-05-05
-$823.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$151.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$15.00M
derived: sum of 2 quarters · filed 2026-02-26
-$82.00M
derived: sum of 3 quarters · filed 2026-02-26
$116.00M
10-K · filed 2026-02-26
2024-09-29-$166.00M
10-Q · filed 2025-11-04
-$233.00M
derived: sum of 2 quarters · filed 2025-11-04
-$35.00M
10-Q · filed 2025-11-04
-$34.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$67.00M
10-Q · filed 2025-08-05
$131.00M
10-Q · filed 2025-08-05
$132.00M
derived: sum of 3 quarters · filed 2026-02-26
$266.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$198.00M
10-Q · filed 2025-05-05
$199.00M
derived: sum of 2 quarters · filed 2026-02-26
$333.00M
derived: sum of 3 quarters · filed 2026-02-26
$517.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$135.00M
derived: sum of 2 quarters · filed 2026-02-26
$319.00M
derived: sum of 3 quarters · filed 2026-02-26
$331.00M
10-K · filed 2026-02-26
2023-10-01$134.00M
10-Q · filed 2024-11-04
$318.00M
derived: sum of 2 quarters · filed 2024-11-04
$330.00M
10-Q · filed 2024-11-04
$247.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-07-02$184.00M
10-Q · filed 2024-08-05
$196.00M
10-Q · filed 2024-08-05
$113.00M
derived: sum of 3 quarters · filed 2025-02-27
-$998.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-04-02$12.00M
10-Q · filed 2024-05-08
-$71.00M
derived: sum of 2 quarters · filed 2025-02-27
-$1.18B
derived: sum of 3 quarters · filed 2025-02-27
-$2.15B
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$83.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$1.19B
derived: sum of 2 quarters · filed 2025-02-27
-$2.16B
derived: sum of 3 quarters · filed 2025-02-27
-$2.42B
10-K · filed 2025-02-27
2022-10-02-$1.11B
10-Q · filed 2023-11-08
-$2.08B
derived: sum of 2 quarters · filed 2023-11-08
-$2.34B
10-Q · filed 2023-11-08
-$2.59B
derived: sum of 4 quarters · filed 2024-02-22
2022-07-03-$968.00M
10-Q · filed 2023-08-09
-$1.23B
10-Q · filed 2023-08-09
-$1.48B
derived: sum of 3 quarters · filed 2024-02-22
-$2.37B
derived: sum of 4 quarters · filed 2024-02-22
2022-04-03-$260.00M
10-Q · filed 2023-05-10
-$511.00M
derived: sum of 2 quarters · filed 2024-02-22
-$1.41B
derived: sum of 3 quarters · filed 2024-02-22
-$1.50B
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$251.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$1.15B
derived: sum of 2 quarters · filed 2024-02-22
-$1.24B
derived: sum of 3 quarters · filed 2024-02-22
-$589.00M
10-K · filed 2024-02-22
2021-10-03-$894.00M
10-Q · filed 2022-11-09
-$986.00M
derived: sum of 2 quarters · filed 2022-11-09
-$338.00M
10-Q · filed 2022-11-09
$461.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-07-04-$92.00M
10-Q · filed 2022-08-10
$556.00M
10-Q · filed 2022-08-10
$1.35B
derived: sum of 3 quarters · filed 2023-02-23
$2.65B
derived: sum of 4 quarters · filed 2023-02-23
2021-04-04$647.00M
10-Q · filed 2022-05-11
$1.45B
derived: sum of 2 quarters · filed 2023-02-23
$2.75B
derived: sum of 3 quarters · filed 2023-02-23
$2.56B
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$800.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$2.10B
derived: sum of 2 quarters · filed 2023-02-23
$1.91B
derived: sum of 3 quarters · filed 2023-02-23
$471.00M
10-K · filed 2023-02-23
$14.00M
10-K · filed 2021-02-25
2020-09-27$1.30B
10-Q · filed 2021-11-12
$572.00M
10-Q · filed 2020-11-05
$1.11B
derived: sum of 2 quarters · filed 2021-11-12
-$329.00M
10-Q · filed 2021-11-12
-$1.04B
10-Q · filed 2020-11-05
$77.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-28-$187.00M
10-Q · filed 2021-08-12
-$127.00M
10-Q · filed 2020-08-06
-$1.63B
10-Q · filed 2021-08-12
-$1.62B
10-Q · filed 2020-08-06
-$1.22B
derived: sum of 3 quarters · filed 2022-02-24
-$1.50B
derived: sum of 4 quarters · filed 2022-02-24
2020-03-29-$1.44B
10-Q · filed 2021-05-13
-$1.49B
10-Q · filed 2020-05-07
-$1.03B
derived: sum of 2 quarters · filed 2022-02-24
-$1.31B
derived: sum of 3 quarters · filed 2022-02-24
-$1.92B
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$406.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$131.00M
derived: sum of 2 quarters · filed 2022-02-24
-$479.00M
derived: sum of 3 quarters · filed 2022-02-24
-$130.00M
10-K · filed 2022-02-24
-$376.00M
10-K · filed 2020-02-27
2019-09-29-$275.00M
10-Q · filed 2020-11-05
-$885.00M
derived: sum of 2 quarters · filed 2020-11-05
-$536.00M
10-Q · filed 2020-11-05
-$1.40B
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$610.00M
10-Q · filed 2020-08-06
-$262.00M
10-Q · filed 2020-08-06
-$1.12B
derived: sum of 3 quarters · filed 2021-02-25
-$1.54B
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$348.00M
10-Q · filed 2020-05-07
-$511.00M
derived: sum of 2 quarters · filed 2021-02-25
-$933.00M
derived: sum of 3 quarters · filed 2021-02-25
-$1.55B
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$859.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$1.28B
derived: sum of 2 quarters · filed 2021-02-25
-$1.89B
derived: sum of 3 quarters · filed 2021-02-25
-$1.98B
10-K · filed 2021-02-25
2018-09-30-$422.00M
10-Q · filed 2019-11-07
-$1.03B
derived: sum of 2 quarters · filed 2019-11-07
-$1.12B
10-Q · filed 2019-11-07
-$1.27B
derived: sum of 4 quarters · filed 2020-02-27
2018-07-01-$613.00M
10-Q · filed 2019-08-08
-$693.00M
10-Q · filed 2019-08-08
-$851.00M
derived: sum of 3 quarters · filed 2020-02-27
$167.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-04-01-$80.00M
10-Q · filed 2019-05-09
-$238.00M
derived: sum of 2 quarters · filed 2020-02-27
$780.00M
derived: sum of 3 quarters · filed 2020-02-27
$1.20B
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$158.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$860.00M
derived: sum of 2 quarters · filed 2020-02-27
$1.28B
derived: sum of 3 quarters · filed 2020-02-27
$1.73B
10-K · filed 2020-02-27
2017-10-01$1.02B
10-Q · filed 2018-11-08
$1.44B
derived: sum of 2 quarters · filed 2018-11-08
$1.89B
10-Q · filed 2018-11-08
-$936.00M
derived: sum of 4 quarters · filed 2019-02-28
2017-07-02$421.00M
10-Q · filed 2018-08-09
$870.00M
10-Q · filed 2018-08-09
-$1.95B
derived: sum of 3 quarters · filed 2019-02-28
-$1.28B
derived: sum of 4 quarters · filed 2019-02-28
2017-04-02$449.00M
10-Q · filed 2018-05-10
-$2.38B
derived: sum of 2 quarters · filed 2019-02-28
-$1.70B
derived: sum of 3 quarters · filed 2019-02-28
-$1.06B
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$2.82B
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$2.15B
derived: sum of 2 quarters · filed 2019-02-28
-$1.51B
derived: sum of 3 quarters · filed 2019-02-28
-$1.52B
10-K · filed 2019-02-28
2016-10-02$677.00M
10-Q · filed 2017-11-09
$678.00M
10-Q · filed 2016-11-10
$1.31B
derived: sum of 2 quarters · filed 2017-11-09
$1.31B
10-Q · filed 2017-11-09
$1.31B
10-Q · filed 2016-11-10
$952.00M
derived: sum of 4 quarters · filed 2018-02-22
2016-07-03$633.00M
10-Q · filed 2017-08-10
$629.00M
10-Q · filed 2017-08-10
$275.00M
derived: sum of 3 quarters · filed 2018-02-22
-$381.00M
derived: sum of 4 quarters · filed 2018-02-22
2016-04-03-$4.00M
10-Q · filed 2017-05-11
-$358.00M
derived: sum of 2 quarters · filed 2018-02-22
-$1.01B
derived: sum of 3 quarters · filed 2018-02-22
-$979.00M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31-$354.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
-$1.01B
derived: sum of 2 quarters · filed 2018-02-22
-$975.00M
derived: sum of 3 quarters · filed 2018-02-22
-$2.23B
10-K · filed 2018-02-22
2015-09-27-$656.00M
10-Q · filed 2016-11-10
-$621.00M
derived: sum of 2 quarters · filed 2016-11-10
-$1.88B
10-Q · filed 2016-11-10
-$5.73B
derived: sum of 4 quarters · filed 2017-02-23
2015-06-28$35.00M
10-Q · filed 2016-08-11
-$1.22B
10-Q · filed 2016-08-11
-$5.08B
derived: sum of 3 quarters · filed 2017-02-23
-$5.39B
derived: sum of 4 quarters · filed 2017-02-23
2015-03-29-$1.26B
10-Q · filed 2016-05-12
-$5.11B
derived: sum of 2 quarters · filed 2017-02-23
-$5.43B
derived: sum of 3 quarters · filed 2017-02-23
-$5.18B
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31-$3.85B
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
-$4.17B
derived: sum of 2 quarters · filed 2017-02-23
-$3.92B
derived: sum of 3 quarters · filed 2017-02-23
-$4.04B
10-K · filed 2017-02-23
2014-09-28-$320.00M
10-Q · filed 2015-11-05
-$67.00M
derived: sum of 2 quarters · filed 2015-11-05
-$189.00M
10-Q · filed 2015-11-05
$2.90B
derived: sum of 4 quarters · filed 2016-02-29
2014-06-29$253.00M
10-Q · filed 2015-08-06
$132.00M
10-Q · filed 2015-08-06
$3.22B
derived: sum of 3 quarters · filed 2016-02-29
$3.26B
derived: sum of 4 quarters · filed 2016-02-29
2014-03-30-$121.00M
10-Q · filed 2015-05-07
$2.97B
derived: sum of 2 quarters · filed 2016-02-29
$3.01B
derived: sum of 3 quarters · filed 2016-02-29
$2.68B
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$3.09B
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$3.13B
derived: sum of 2 quarters · filed 2016-02-29
$2.80B
derived: sum of 3 quarters · filed 2016-02-29
$2.59B
10-K · filed 2016-02-29
2013-09-29$41.00M
10-Q · filed 2014-11-06
-$290.00M
derived: sum of 2 quarters · filed 2014-11-06
-$495.00M
10-Q · filed 2014-11-06
-$783.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30-$331.00M
10-Q · filed 2014-08-07
-$536.00M
10-Q · filed 2014-08-07
-$824.00M
derived: sum of 3 quarters · filed 2015-02-27
-$470.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31-$205.00M
10-Q · filed 2014-05-08
-$493.00M
derived: sum of 2 quarters · filed 2015-02-27
-$139.00M
derived: sum of 3 quarters · filed 2015-02-27
-$2.54B
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31-$288.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$66.00M
derived: sum of 2 quarters · filed 2015-02-27
-$2.34B
derived: sum of 3 quarters · filed 2015-02-27
-$1.83B
10-K · filed 2015-02-27
2012-09-30$354.00M
10-Q · filed 2013-11-08
-$2.05B
derived: sum of 2 quarters · filed 2013-11-08
-$1.54B
10-Q · filed 2013-11-08
-$4.50B
derived: sum of 4 quarters · filed 2014-02-28
2012-07-01-$2.40B
10-Q · filed 2013-08-09
-$1.90B
10-Q · filed 2013-08-09
-$4.86B
derived: sum of 3 quarters · filed 2014-02-28
-$5.12B
derived: sum of 4 quarters · filed 2014-02-28
2012-04-01$506.00M
10-Q · filed 2013-05-10
-$2.46B
derived: sum of 2 quarters · filed 2014-02-28
-$2.72B
derived: sum of 3 quarters · filed 2014-02-28
-$1.61B
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31-$2.96B
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
-$3.22B
derived: sum of 2 quarters · filed 2014-02-28
-$2.12B
derived: sum of 3 quarters · filed 2014-02-28
-$734.00M
10-K · filed 2014-02-28
2011-10-02-$262.00M
10-Q · filed 2012-11-09
$844.00M
derived: sum of 2 quarters · filed 2012-11-09
$2.23B
10-Q · filed 2012-11-09
2011-07-03$1.11B
10-Q · filed 2012-08-09
$2.49B
10-Q · filed 2012-08-09
2010-12-31-$3.99B
10-K · filed 2013-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64